Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingzhen Zhou

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Medicine|August 24, 2022
Immunotherapy for hepatocellular carcinomaMingzhen Zhou, Baorui Liu, Jie Shen
RSC Advances|April 28, 2022
Polyethylene glycol-derived polyelectrolyte-protein nanoclusters for protein drug deliveryYuanxiang Yu, Yi Shao, Mingzhen Zhou, et al.
Cancer Letters|December 26, 2024
Neutrophils in cancer drug resistance: Roles and therapeutic opportunitiesHao Liu, Hongyu Zhao, Mingzhen Zhou, et al.
Investigational New Drugs|February 10, 2023
A phase Ib/II study of BLU-554, a fibroblast growth factor receptor 4 inhibitor in combination with CS1001, an anti-PD-L1, in patients with locally advanced or metastatic hepatocellular carcinomaMingzhen Zhou, Sihui Zhu, Chen Xu, et al.
Biomed Research International|November 8, 2021
Bioinformatic Evidence Reveals that Cell Cycle Correlated Genes Drive the Communication between Tumor Cells and the Tumor Microenvironment and Impact the Outcomes of Hepatocellular CarcinomaDongdong Chen, Zhijun Feng, Mingzhen Zhou, et al.
Cancer Biology & Medicine|April 28, 2026
Tumor microenvironment-driven natural killer cell diversity: mechanisms and therapeutic opportunitiesYue Duan, Mingzhen Zhou, Xingxian Guo, et al.
Discover Oncology|November 3, 2025
Intracavitary infusion of FOLactis Lactobacillus leads to disappearance of MPE in patient with advanced lung adenocarcinomaMingzhen Zhou, Juan Zhang, Sihui Zhu, et al.
Antioxidants & Redox Signaling|April 1, 2023
Redox Dysregulation in the Tumor Microenvironment Contributes to Cancer MetastasisWanning Liu, Boda Wang, Mingzhen Zhou, et al.
Scientific Reports|August 28, 2024
CT radiomics-based biomarkers can predict response to immunotherapy in hepatocellular carcinomaLiang Qi, Yahui Zhu, Jinxin Li, et al.
Journal of Translational Medicine|January 21, 2025
Multiplex immunohistochemistry to explore the tumor immune microenvironment in HCC patients with different GPC3 expressionMingzhen Zhou, Ziyan Zhou, Lina Hu, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Medicine|August 24, 2022
Immunotherapy for hepatocellular carcinomaMingzhen Zhou, Baorui Liu, Jie Shen
RSC Advances|April 28, 2022
Polyethylene glycol-derived polyelectrolyte-protein nanoclusters for protein drug deliveryYuanxiang Yu, Yi Shao, Mingzhen Zhou, et al.
Cancer Letters|December 26, 2024
Neutrophils in cancer drug resistance: Roles and therapeutic opportunitiesHao Liu, Hongyu Zhao, Mingzhen Zhou, et al.
Investigational New Drugs|February 10, 2023
A phase Ib/II study of BLU-554, a fibroblast growth factor receptor 4 inhibitor in combination with CS1001, an anti-PD-L1, in patients with locally advanced or metastatic hepatocellular carcinomaMingzhen Zhou, Sihui Zhu, Chen Xu, et al.
Biomed Research International|November 8, 2021
Bioinformatic Evidence Reveals that Cell Cycle Correlated Genes Drive the Communication between Tumor Cells and the Tumor Microenvironment and Impact the Outcomes of Hepatocellular CarcinomaDongdong Chen, Zhijun Feng, Mingzhen Zhou, et al.
Cancer Biology & Medicine|April 28, 2026
Tumor microenvironment-driven natural killer cell diversity: mechanisms and therapeutic opportunitiesYue Duan, Mingzhen Zhou, Xingxian Guo, et al.
Discover Oncology|November 3, 2025
Intracavitary infusion of FOLactis Lactobacillus leads to disappearance of MPE in patient with advanced lung adenocarcinomaMingzhen Zhou, Juan Zhang, Sihui Zhu, et al.
Antioxidants & Redox Signaling|April 1, 2023
Redox Dysregulation in the Tumor Microenvironment Contributes to Cancer MetastasisWanning Liu, Boda Wang, Mingzhen Zhou, et al.
Scientific Reports|August 28, 2024
CT radiomics-based biomarkers can predict response to immunotherapy in hepatocellular carcinomaLiang Qi, Yahui Zhu, Jinxin Li, et al.
Journal of Translational Medicine|January 21, 2025
Multiplex immunohistochemistry to explore the tumor immune microenvironment in HCC patients with different GPC3 expressionMingzhen Zhou, Ziyan Zhou, Lina Hu, et al.
Pageof 3